These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 15458850

  • 1. Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode.
    Gervasoni N, Bertschy G, Osiek C, Perret G, Denis R, Golaz J, Rossier MF, Bondolfi G, Aubry JM.
    J Psychiatr Res; 2004; 38(6):553-7. PubMed ID: 15458850
    [Abstract] [Full Text] [Related]

  • 2. Combined dexamethasone/CRF test in remitted outpatients with recurrent major depressive disorder.
    Van Den Eede F, Van den Bossche B, Hulstijn W, Sabbe BG, Cosyns P, Claes SJ.
    J Affect Disord; 2006 Jul; 93(1-3):259-63. PubMed ID: 16677715
    [Abstract] [Full Text] [Related]

  • 3. The dex/CRH test--is it better than the DST?
    Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH.
    Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
    [Abstract] [Full Text] [Related]

  • 4. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

  • 5. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M, Horstmann S, Kloiber S, Lucae S, Binder EB, Kern N, Künzel HE, Pfennig A, Uhr M, Holsboer F.
    Biol Psychiatry; 2007 Jul 01; 62(1):47-54. PubMed ID: 17123470
    [Abstract] [Full Text] [Related]

  • 6. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
    Psychoneuroendocrinology; 2008 Apr 01; 33(3):313-20. PubMed ID: 18215470
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb 01; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

  • 8. The DEX/CRH neuroendocrine test and the prediction of depressive relapse in remitted depressed outpatients.
    Aubry JM, Gervasoni N, Osiek C, Perret G, Rossier MF, Bertschy G, Bondolfi G.
    J Psychiatr Res; 2007 Feb 01; 41(3-4):290-4. PubMed ID: 16956623
    [Abstract] [Full Text] [Related]

  • 9. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression).
    Appelhof BC, Huyser J, Verweij M, Brouwer JP, van Dyck R, Fliers E, Hoogendijk WJ, Tijssen JG, Wiersinga WM, Schene AH.
    Biol Psychiatry; 2006 Apr 15; 59(8):696-701. PubMed ID: 16368077
    [Abstract] [Full Text] [Related]

  • 10. The influence of psychiatric comorbidity on the dexamethasone/CRH test in major depression.
    Veen G, Derijk RH, Giltay EJ, van Vliet IM, van Pelt J, Zitman FG.
    Eur Neuropsychopharmacol; 2009 Jun 15; 19(6):409-15. PubMed ID: 19327969
    [Abstract] [Full Text] [Related]

  • 11. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
    Muhtz C, Wester M, Yassouridis A, Wiedemann K, Kellner M.
    J Psychiatr Res; 2008 Jul 15; 42(8):689-93. PubMed ID: 17884095
    [Abstract] [Full Text] [Related]

  • 12. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
    Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJ.
    Biol Psychiatry; 1995 Dec 15; 38(12):797-802. PubMed ID: 8750037
    [Abstract] [Full Text] [Related]

  • 13. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan 15; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 14. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
    Aihara M, Ida I, Yuuki N, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H, Mikuni M.
    Psychiatry Res; 2007 Aug 15; 155(3):245-56. PubMed ID: 17587554
    [Abstract] [Full Text] [Related]

  • 15. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
    Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC.
    J Psychiatr Res; 2007 Aug 15; 41(1-2):131-43. PubMed ID: 16455105
    [Abstract] [Full Text] [Related]

  • 16. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M.
    Neuropsychopharmacology; 2006 Jan 15; 31(1):212-20. PubMed ID: 16123748
    [Abstract] [Full Text] [Related]

  • 17. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
    Van Den Eede F, Moorkens G, Hulstijn W, Van Houdenhove B, Cosyns P, Sabbe BG, Claes SJ.
    Psychol Med; 2008 Jul 15; 38(7):963-73. PubMed ID: 17803834
    [Abstract] [Full Text] [Related]

  • 18. The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal.
    Hundt W, Zimmermann U, Pöttig M, Spring K, Holsboer F.
    Alcohol Clin Exp Res; 2001 May 15; 25(5):687-91. PubMed ID: 11371718
    [Abstract] [Full Text] [Related]

  • 19. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
    Psychoneuroendocrinology; 2004 Oct 15; 29(9):1101-8. PubMed ID: 15219633
    [Abstract] [Full Text] [Related]

  • 20. Brain-derived neurotrophic factor Val66Met polymorphism and dexamethasone/CRH test results in depressed patients.
    Schüle C, Zill P, Baghai TC, Eser D, Zwanzger P, Wenig N, Rupprecht R, Bondy B.
    Psychoneuroendocrinology; 2006 Sep 15; 31(8):1019-25. PubMed ID: 16890377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.